Possible adverse effect of methylglucamine diatrizoate compounds on the bowel of newborn infants with meconium ileus.
Gastrografin (methylglucamine diatrizoate) enemas were carried out in 2 newborn infants with meconium ileus. Evacuation was slow and incomplete. Both patients died within 72 hours following enemas from bowel necrosis, perforation and peritonitis. Although it is not possible to implicate Gastrografin directly as the cause, it is suggested that it may have contributed substantially to bowel necrosis. Recent experimental evidence of colonic inflammation and occasionally necrosis caused by Gastrografin lends support to this hypothesis. Caution should be exercised to prevent not only the systemic osmotic effects of Gastrografin, but also potential local injury to the bowel, especially when underlying disease interferes with intestinal viability.
D003973:Diatrizoate / Q000031:analogs & derivatives*; D003974:Diatrizoate Meglumine / Q000009:adverse effects*; D004733:Enema / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007410:Intestinal Diseases / Q000139:chemically induced*; D007415:Intestinal Obstruction / Q000000981:diagnostic imaging / Q000628:therapy*; D008470:Meconium; D009336:Necrosis / Q000139:chemically induced*; D011859:Radiography
D003973:Diatrizoate; D003974:Diatrizoate Meglumine